Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-30
2006-05-30
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S504000, C540S505000, C540S506000, C540S509000, C540S517000, C540S518000
Reexamination Certificate
active
07053084
ABSTRACT:
This invention relates to novel lactams having the formula (I):to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of Aβ-peptide, thereby acting to prevent the formation of neurological deposits of amyloid protein. More particularly, the present invention relates to the treatment of neurological disorders related to β-amyloid production such as Alzheimer's disease and Down's Syndrome.
REFERENCES:
patent: 3651023 (1972-03-01), Ottenheym et al.
patent: 4929614 (1990-05-01), Calvet et al.
patent: 5283241 (1994-02-01), Bochis et al.
patent: 5532359 (1996-07-01), Marsters et al.
patent: 5550126 (1996-08-01), Horwell et al.
patent: 5578629 (1996-11-01), Ciccarone et al.
patent: 5595990 (1997-01-01), Baldwin et al.
patent: 5602145 (1997-02-01), Samanen
patent: 5602156 (1997-02-01), Kohn et al.
patent: 5618812 (1997-04-01), Castro Pineiro et al.
patent: 5672596 (1997-09-01), Wyvratt et al.
patent: 5672598 (1997-09-01), De et al.
patent: 5703129 (1997-12-01), Felsenstein et al.
patent: 5710153 (1998-01-01), Ohmoto et al.
patent: 5710171 (1998-01-01), Dinsmore et al.
patent: 5756528 (1998-05-01), Anthony et al.
patent: 5763437 (1998-06-01), Sato et al.
patent: 5770573 (1998-06-01), Arrhenius et al.
patent: 5852010 (1998-12-01), Graham et al.
patent: 5856326 (1999-01-01), Anthony et al.
patent: 5859012 (1999-01-01), Dinsmore et al.
patent: 5869682 (1999-02-01), DeSolms
patent: 5872135 (1999-02-01), DeSolms
patent: 5885995 (1999-03-01), Dinsmore
patent: 5891889 (1999-04-01), Anthony et al.
patent: 5905077 (1999-05-01), Jungheim et al.
patent: 5919785 (1999-07-01), Dinsmore et al.
patent: 5936089 (1999-08-01), Carpino et al.
patent: 5965578 (1999-10-01), Graham et al.
patent: 5985900 (1999-11-01), Bender et al.
patent: 5998407 (1999-12-01), Graham et al.
patent: 2003/0134841 (2003-07-01), Olson et al.
patent: 0421802 (1991-04-01), None
patent: 0434360 (1991-06-01), None
patent: 0842944 (1998-05-01), None
patent: WO 9217460 (1992-10-01), None
patent: WO 9403437 (1994-02-01), None
patent: WO 9405634 (1994-03-01), None
patent: WO 9414776 (1994-07-01), None
patent: WO 9509633 (1995-04-01), None
patent: WO 9617833 (1996-06-01), None
patent: WO 9618602 (1996-06-01), None
patent: WO 9620918 (1996-07-01), None
patent: WO 9629313 (1996-09-01), None
patent: WO 9633165 (1996-10-01), None
patent: WO 9639137 (1996-12-01), None
patent: WO 9712861 (1997-04-01), None
patent: WO 9719053 (1997-05-01), None
patent: WO 9727852 (1997-08-01), None
patent: WO 9736877 (1997-10-01), None
patent: WO 9736879 (1997-10-01), None
patent: WO 9736900 (1997-10-01), None
patent: WO 9738664 (1997-10-01), None
patent: WO 9745412 (1997-12-01), None
patent: WO 9816523 (1998-04-01), None
patent: WO 9822430 (1998-05-01), None
patent: WO 9822433 (1998-05-01), None
patent: WO 9822441 (1998-05-01), None
patent: WO 9822493 (1998-05-01), None
patent: WO 9827053 (1998-06-01), None
patent: WO 9828268 (1998-07-01), None
patent: WO 9828980 (1998-07-01), None
patent: WO 9835941 (1998-08-01), None
patent: WO 9837079 (1998-08-01), None
patent: WO 9841510 (1998-09-01), None
patent: WO 9844797 (1998-10-01), None
patent: WO 9858915 (1998-12-01), None
patent: WO 9900654 (1999-01-01), None
patent: WO 9903826 (1999-01-01), None
patent: WO 9907730 (1999-02-01), None
patent: WO 9907731 (1999-02-01), None
patent: WO 9917777 (1999-04-01), None
patent: WO 9918951 (1999-04-01), None
patent: WO 9919305 (1999-04-01), None
patent: WO 9932453 (1999-07-01), None
patent: WO 9966934 (1999-12-01), None
patent: WO 9967219 (1999-12-01), None
patent: WO 9967220 (1999-12-01), None
patent: WO 9967221 (1999-12-01), None
patent: WO 0002903 (2000-01-01), None
patent: WO 0007995 (2000-02-01), None
patent: WO 0028331 (2000-05-01), None
patent: WO 0038618 (2000-07-01), None
patent: WO 0160826 (2001-08-01), None
Dingwall; J. Clinical Invest., 108, Nov. 2001, 1243-1246.
Selkoe; J. Alzheimer's Disease, 3, 2001, p. 75-81.
Olson et al., Current Opinion in Drug Discovery and Development, 4, 2001, p. 390-401.
Su San Mok et al, A Novel Metalloprotease in Rat rain cleaves . . . Biochemistry, vol. 36, No. 1, 1997, pp. 156-163 XP002177252.
Database WPI, Section Ch, Week 199839, Derwent Pub. Ltd., London GB; Class B02, AN 1998-457046 XP002203452, 1998.
Patani et al, Bioisosterism: A Rational Approach in Drug Design, Chem. Rev., 1996, 96, 3147-3176 XP000652176.
Natchus et al, Design and Synthesis of Conformationally-Constrained MMP Inhibitors, Bioorganic & Medicinal Chem. Letters 8 (1998) 2077-2080 XP004137222.
Yong et al, Matrix Metalloproteinases and Diseases of the CNS, TINS vol. 21, No. 2, 1998 75-80 XP000942162.
International Search Report PCT/US99/30815 dated Apr. 17, 2000.
Algieri Aldo A.
Bristol--Myers Squibb Company
Coleman Brenda
Kelly Drye & Warren LLP
LandOfFree
Succinoylamino benzodiazepines as inhibitors of Aβ... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Succinoylamino benzodiazepines as inhibitors of Aβ..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Succinoylamino benzodiazepines as inhibitors of Aβ... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3528451